e.l.f. Beauty (ELF) Form 144 Notices Proposed Sale of 55,581 Shares
Rhea-AI Filing Summary
e.l.f. Beauty, Inc. (ELF) filed a Form 144 to report a proposed sale of company common stock by an insider. The notice names Morgan Stanley Smith Barney LLC as the broker and indicates 55,581 shares may be sold on or about 09/10/2025 on the NYSE, with an aggregate market value of $7,716,310.23 and total shares outstanding listed as 56,734,903. The securities were largely acquired by exercise of stock options on 09/10/2025 (50,581 shares, paid in cash) and restricted stock units on 06/01/2024 (5,000 shares). The filer certifies there are no undisclosed material adverse facts and reports no shares sold in the past three months.
Positive
- Clear disclosure of planned sale including broker (Morgan Stanley Smith Barney LLC), share count (55,581) and aggregate value ($7,716,310.23)
- Acquisition details provided: 50,581 shares from option exercise and 5,000 from restricted stock units with acquisition and payment dates listed
- No reported sales in prior three months, indicating this is a newly disclosed proposed sale rather than part of recent trading activity
Negative
- None.
Insights
TL;DR: Routine Form 144 filing: insider plans to sell 55,581 shares (~$7.72M) via Morgan Stanley on 09/10/2025.
The filing documents a proposed sale of 55,581 common shares, identifying the broker, the planned sale date, and the acquisition details: most shares resulted from option exercises on the same date and a smaller portion from restricted stock units granted in 2024. No sales in the prior three months are reported. For investors, this is a disclosure of an insider liquidity event rather than an operational update; the filing does not state any material undisclosed information.
TL;DR: Compliance disclosure appears complete for Rule 144 purposes; includes broker, acquisition dates, and seller representation.
The Form 144 includes the required elements: broker name and address, class and number of shares, aggregate market value, outstanding shares, acquisition dates and nature (option exercise and RSUs), and an explicit signature representation regarding material nonpublic information. The document indicates reliance on standard Rule 144 disclosures and records no recent sales. No regulatory exceptions or 10b5-1 plan date are indicated in the remarks section.